CYTLIMIC

CYTLIMIC is a biotechnology company developing immunotherapy products for the treatment of cancer, including a cancer peptide vaccine. CYTLIMIC’s products aim to activate immune systems to attack cancer cells while enabling patients to maintain a high quality-of-life during treatment.

#People #Financial #Website #More

CYTLIMIC

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2016-12-16

Address:

Higashi-shinagawa, Tokyo, Japan

Country:

Japan

Website Url:

http://www.cytlimic.com

Total Employee:

Status:

Active

Total Funding:

20.85 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Nginx

Current Advisors List

not_available_image

Fujikawa Osamu Executive Officer @ Cytlimic
Board_member

not_available_image

Toi Shun Chairman @ Cytlimic
Board_member

not_available_image

Hiromichi Kimura Directors @ Cytlimic
Board_member

not_available_image

Ken Nakamura Director @ Cytlimic
Board_member

not_available_image

Koichi Niide Auditor @ Cytlimic
Board_member

Current Employees Featured

not_available_image

Minori Saito
Minori Saito Chief Executive Officer, President & Board Member @ Cytlimic
Chief Executive Officer, President & Board Member

not_available_image

Yoshihide segawa
Yoshihide segawa Chief Operating Officer @ Cytlimic
Chief Operating Officer
2017-04-01

Founder

shun-doi_image

Shun Doi

Investors List

smbc-venture-capital_image

Official Site Inspections

http://www.cytlimic.com

Host Informations
Whois Informations

Loading ...